Skip to content

13F-HR filed by Casdin Capital, LLC

Casdin Capital, LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 31 holding rows worth $568,612,000.

Accession
0001172661-18-001199
Filed
2018-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 31 entries on the cover page, a total value of $568,612,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $568,612,000 with VALUE read as thousands by filing date, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LOXO ONCOLOGY INC548862101COM360,000$41,533,000thousands by filing date
Foundation Medicine Inc350465100COM520,000$40,950,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM250,000$40,268,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM348,000$31,912,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM463,000$30,831,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM364,776$29,831,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock250,000$29,775,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM600,000$28,980,000thousands by filing date
MYOKARDIA INC62857M105COM560,000$27,328,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM1,400,000$26,600,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM2,600,000$25,376,000thousands by filing date
BLUEBIRD BIO INC09609G100COM145,000$24,759,000thousands by filing date
CODEXIS INC192005106COM2,025,000$22,275,000thousands by filing date
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK1,135,000$21,327,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM3,850,000$20,944,000thousands by filing date
ILLUMINA INC452327109COM71,500$16,904,000thousands by filing date
EVOLENT HEALTH INC CL A30050B101Stock1,110,000$15,818,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM635,000$14,192,000thousands by filing date
AUDENTES THERAPEUTICS INC.05070R104Common Stock450,000$13,523,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR70,000$11,760,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH95,000$10,140,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM177,500$9,372,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock135,000$6,171,000thousands by filing date
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK207,500$5,903,000thousands by filing date
EDITAS MEDICINE INC28106W103COM133,333$4,420,000thousands by filing date
NEOGEN CORP640491106COM65,000$4,354,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM240,000$4,054,000thousands by filing date
CELGENE CORP151020104COM40,000$3,568,000thousands by filing datecall
ZAI LAB LTD ADR98887Q104ADR135,000$2,882,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock300,000$1,740,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM60,000$1,122,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-18-001199this filing2018-05-15acceptance time not in the bulk data set